PapadopoulouLCSueCMDavidsonMMTanjiKNishinoISadlockJEet al
April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Our team will thoroughly assess your medical history, discuss potential benefits and risks, and guide you through the process with informed consent
Inositol is a key substrate in glucose metabolism and is a second messenger in insulin action
By the second or third month, progress may feel more noticeable in clothing fit, energy, or eating behavior
Waghmare PH, Lindsey R, Reed JB, Gao S, Zillich AJ Systematic review of the impact of medication synchronization on healthcare utilization, economic, clinical, and humanistic outcomes